| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B G Darnay, B B Aggarwa. Early events in TNF signaling: a story of associations and dissociations. Journal of leukocyte biology. vol 61. issue 5. 1997-05-21. PMID:9129204. |
in this review, we summarize these and other tnf receptor-associated proteins and their potential roles in regulating the activation of nuclear factor-kappab and apoptosis, two major responses activated by engagement of tnf receptors by the ligand. |
1997-05-21 |
2023-08-12 |
Not clear |
| J Seong, C G Milross, N R Hunter, H C Shin, L Mila. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha. Anti-cancer drugs. vol 8. issue 1. 1997-05-15. PMID:9147616. |
our aim was to determine whether tnf increases the antitumor efficacy of paclitaxel and if so whether the increase is mediated through the enhancement of apoptosis induction by paclitaxel. |
1997-05-15 |
2023-08-12 |
mouse |
| J Seong, C G Milross, N R Hunter, H C Shin, L Mila. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha. Anti-cancer drugs. vol 8. issue 1. 1997-05-15. PMID:9147616. |
histological analysis of treated mca-k tumors revealed that tnf alone did not induce apoptosis of tumor cells, but in the combination it enhanced the apoptotic response to paclitaxel. |
1997-05-15 |
2023-08-12 |
mouse |
| J Seong, C G Milross, N R Hunter, H C Shin, L Mila. Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha. Anti-cancer drugs. vol 8. issue 1. 1997-05-15. PMID:9147616. |
thus, tnf increased the antitumor efficacy of paclitaxel by enhancing cellular sensitivity to paclitaxel's induction of apoptosis. |
1997-05-15 |
2023-08-12 |
mouse |
| I Kitajima, T Nakajima, T Imamura, I Takasaki, K Kawahara, T Okano, T Tokioka, Y Soejima, K Abeyama, I Maruyam. Induction of apoptosis in murine clonal osteoblasts expressed by human T-cell leukemia virus type I tax by NF-kappa B and TNF-alpha. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. vol 11. issue 2. 1997-04-29. PMID:8822344. |
this apoptosis was prevented by treatment with neutralizing anti-tnf-alpha antibody (alpha tnf). |
1997-04-29 |
2023-08-12 |
human |
| M Higuchi, B B Aggarwal, E T Ye. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. The Journal of clinical investigation. vol 99. issue 7. 1997-04-24. PMID:9120020. |
in contrast, inhibition of proliferation and induction of differentiation by tnf were still observed in respiration deficient clones, suggesting a selective requirement of respiration in tnf-induced apoptosis. |
1997-04-24 |
2023-08-12 |
Not clear |
| M Higuchi, B B Aggarwal, E T Ye. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. The Journal of clinical investigation. vol 99. issue 7. 1997-04-24. PMID:9120020. |
next, we showed that apoptosis induced by tnf and staurosporine were blocked by z-devd-ch2f, an inhibitor of cpp32-like cysteine protease, suggesting the involvement of cpp32-like protease in both apoptosis signaling pathways. |
1997-04-24 |
2023-08-12 |
Not clear |
| G Pan, K O'Rourke, A M Chinnaiyan, R Gentz, R Ebner, J Ni, V M Dixi. The receptor for the cytotoxic ligand TRAIL. Science (New York, N.Y.). vol 276. issue 5309. 1997-04-22. PMID:9082980. |
trail (also known as apo-2l) is a member of the tumor necrosis factor (tnf) ligand family that rapidly induces apoptosis in a variety of transformed cell lines. |
1997-04-22 |
2023-08-12 |
human |
| T Dimitrov, P Krajcsi, T W Hermiston, A E Tollefson, M Hannink, W S Wol. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. Journal of virology. vol 71. issue 4. 1997-04-11. PMID:9060638. |
we have reported that three adenovirus (ad) proteins, named e3-10.4k/14.5k, e3-14.7k, and e1b-19k, independently inhibit tumor necrosis factor (tnf)-induced apoptosis in ad-infected cells. |
1997-04-11 |
2023-08-12 |
human |
| M Kawanish. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. Journal of virology. vol 71. issue 4. 1997-04-11. PMID:9060702. |
tumor necrosis factor (tnf) and cytotoxic t lymphocytes, which utilize fas to induce apoptosis in target cells, are known to play a critical role in the host defense against viral infection. |
1997-04-11 |
2023-08-12 |
Not clear |
| M Kawanish. Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. Journal of virology. vol 71. issue 4. 1997-04-11. PMID:9060702. |
these results indicate that the bhrf1 protein protects cells from apoptosis mediated by the tnf receptor and fas. |
1997-04-11 |
2023-08-12 |
Not clear |
| M Kawanish. [Regulation of apoptosis by the latent infection membrane protein 1 of Epstein-Barr virus]. Nihon rinsho. Japanese journal of clinical medicine. vol 55. issue 2. 1997-04-03. PMID:9046815. |
expression of lmp1 in epithelial cells have affected apoptosis induced by tnf-alpha but not apoptosis induced by anti-fas antibodies, suggesting that lmp1 is involved in the signal pathway specific for tnf receptor. |
1997-04-03 |
2023-08-12 |
human |
| S Kettle, A Alcamí, A Khanna, R Ehret, C Jassoy, G L Smit. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. The Journal of general virology. vol 78 ( Pt 3). 1997-03-28. PMID:9049422. |
the b13r protein does, however, block apoptosis mediated by anti-fas antibodies or by tumour necrosis factor (tnf) and cycloheximide. |
1997-03-28 |
2023-08-12 |
mouse |
| S Kettle, A Alcamí, A Khanna, R Ehret, C Jassoy, G L Smit. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. The Journal of general virology. vol 78 ( Pt 3). 1997-03-28. PMID:9049422. |
using dna fragmentation, chromium release and microscopic analyses it was shown that cells infected with wild-type vv strain wr, or a revertant virus in which the b13r gene had been re-inserted into the b13r deletion mutant, are more resistant than uninfected cells or deletion mutant-infected cells to apoptosis mediated by anti-fas and tnf. |
1997-03-28 |
2023-08-12 |
mouse |
| G McFadden, M Schreiber, L Sedge. Myxoma T2 protein as a model for poxvirus TNF receptor homologs. Journal of neuroimmunology. vol 72. issue 2. 1997-03-24. PMID:9042102. |
the m-t2 protein of myxoma virus is a tnf receptor homolog that has two distinct activities: the secreted dimeric m-t2 protein binds and inhibits tnf alpha while the intracellular version permits myxoma virus replication in infected t-lymphocytes by blocking the cellular apoptosis response to the virus infection. |
1997-03-24 |
2023-08-12 |
Not clear |
| M Leist, F Gantner, H Naumann, H Bluethmann, K Vogt, R Brigelius-Flohé, P Nicotera, H D Volk, A Wende. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology. vol 112. issue 3. 1997-03-20. PMID:9041255. |
treatment with tumor necrosis factor (tnf) induces murine hepatocyte apoptosis in vitro and in vivo when sensitizing concentrations of toxins are present. |
1997-03-20 |
2023-08-12 |
mouse |
| M Schreiber, L Sedger, G McFadde. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. Journal of virology. vol 71. issue 3. 1997-03-18. PMID:9032351. |
distinct domains of m-t2, the myxoma virus tumor necrosis factor (tnf) receptor homolog, mediate extracellular tnf binding and intracellular apoptosis inhibition. |
1997-03-18 |
2023-08-12 |
rabbit |
| M Schreiber, L Sedger, G McFadde. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. Journal of virology. vol 71. issue 3. 1997-03-18. PMID:9032351. |
the myxoma virus tumor necrosis factor (tnf) receptor homolog, m-t2, is expressed both as a secreted glycoprotein that inhibits the cytolytic activity of rabbit tnf-alpha and as an endoglycosidase h-sensitive intracellular species that prevents myxoma virus-infected cd4+ t lymphocytes from undergoing apoptosis. |
1997-03-18 |
2023-08-12 |
rabbit |
| M Schreiber, L Sedger, G McFadde. Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. Journal of virology. vol 71. issue 3. 1997-03-18. PMID:9032351. |
to compare the domains of m-t2 mediating extracellular tnf inhibition and intracellular apoptosis inhibition, recombinant myxoma viruses expressing nested c-terminal truncations of m-t2 protein were constructed. |
1997-03-18 |
2023-08-12 |
rabbit |
| S A Marsters, R M Pitti, C J Donahue, S Ruppert, K D Bauer, A Ashkenaz. Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Current biology : CB. vol 6. issue 6. 1997-03-10. PMID:8793301. |
a new member of the tumor necrosis factor (tnf) cytokine family, designated apo-2 ligand (apo-21) [1] or trail [2], has been shown recently to induce apoptosis in various tumor cell lines; however, its biological role is unknown. |
1997-03-10 |
2023-08-12 |
Not clear |